medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2002, Number S1

<< Back Next >>

Arch Cardiol Mex 2002; 72 (S1)

Cardiac arrhythmias in the elderly

Lasses OLA
Full text How to cite this article

Language: Spanish
References: 10
Page: 106-110
PDF size: 58.04 Kb.


Key words:

Elderly persons, Risk factors, Arrhythmias.

ABSTRACT

Cardiac arrhythmias are a major problem in elderly persons, because of the high prevalence of underlying heart disease and hypertension, arrhythmias are associated with significant morbidity and mortality in this age group. Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice. Its incidence increases with age and the presence of structural heart disease. It is a major cause of stroke, especially in the elderly. Although the established principles of evaluation and management of cardiac arrhythmias apply to all age groups, management in the elderly patient is especially challenging because of increased risk of interventional and pharmacologic therapies, altered pharmacokinetics of drugs, and sometimes unclear long-term benefits in the older patient.


REFERENCES

  1. Frishman WH, Heiman M, Karpenos A, Ooi WL, Mitzner A, Goldkorn R, Greenberg S: Twenty-four hour ambulatory electrocardiography in elderly subjects: Prevalence of various arrhythmias and prognostic implications. Am Heart J 1996; 132: 297-302.

  2. Fluckiger L, Boivin JM, Quilliot D, Jeandel C, Zannad F: Differential effects of aging on heart rate variability and blood pressure variability. J Gerontol 1999; 54A: B219-B224.

  3. Zado ES, Callans DJ, Gottlieb CD, Kutalek SP, Wilbur SL, Samuels FL, Hessen SE, Movsowitz CM, Fontaine JM, Kimmel SE, Marchlinski FE: Efficacy and safety of catheter ablation in octogenarians. J Am Coll Cardiol 2000; 35: 458-462.

  4. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 1998; 98: 947-952.

  5. Fifth ACCP Consensus conference on antithrombotic therapy. Chest 1998; 114: 5795-5895.

  6. Lampert R: Management of arrhythmias. Clin Geriatr Med 2000; 16(3): 593-618.

  7. Deedwania PC, Singh BN, Ellenbogan K, Fisher S, Fletcher R, Singh SN: Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT). Circulation 1998; 98: 2574-2579.

  8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 25: 1882-1890.

  9. Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators (CAMIAT). Lancet 1997; 349: 675-682.

  10. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, et al: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on pacemaker implantation). J Am Coll Cardiol 1998; 31: 1175-1209.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2002;72